TRIM28 and central nervous system cancer: Consistent with these molecular studies, KAP1 is amplified in most human cancers, and increased KAP1 expression correlates with poor patient prognosis in multiple tumor types including ovarian, lung, and glioma (Liu et al., 2013; Cui et al., 2014; Wang et al., 2016; Su et al., 2018).